Global insulin delivery devices market from (2018-2025) Insulin pen product type is expected to grow at th | Page 3

Key takeaways:
• In 2017, the homecare setting held more than three – fourths of the market share
• Roche Ltd, Becton and Novo Nordisk, and Medtronic are the leading players
holding approximately around one-third of the market share
•
The insulin pens are anticipated to grow at the highest rate during the forecast
period from 2018 to 2025
•
In 2017, Asia Pacific dominated the global insulin delivery devices market
Some of the key players operating in the global insulin delivery devices market
include Abbott Laboratories, Ypsomad Holding AG, Hoffmann-La Roche Ltd, Terumo
Corporation, Insulet Corporation, Medtronic, Animas Corporation, Becton, Dickinson
and Company, Dexcom, Inc., Sanofi and others.
The global insulin delivery devices market has been segmented on the basis of
product type, end-user and key geographies. Based on product type, the global
insulin delivery devices market comprises of insulin syringes, insulin pens, insulin
pumps and insulin jet injectors. The end user segment includes, homecare setting,
hospitals and others.
The research report “global insulin delivery devices market” provides in-depth
analysis of the insulin delivery devices market across the globe, based on product
type, end users and major geographies for the forecast period from 2018 to 2025.
The report highlights the major market drivers propelling the growth as well as
challenges faced by the market participants. The research report also provides
market size and forecast for insulin delivery devices market. The report also
analyses the competitive landscape, major players and their strategies in 2018. The
competitive landscape section of the report captures and highlights the recent
developments in the market.
For Sample Pages & Detailed Report Description Visit
:https://www.gmiresearch.com/report/global-insulin-delivery-devices-market-syringe-
pen-pump-end-user-share-trends-opportunities-forecast-insights.html